Also from this source

You just read:

ABRAXANE® Plus Gemcitabine Improves Survival in Phase III Study of Patients with Advanced Pancreatic Cancer

News provided by

Specialised Therapeutics Australia Pty Ltd

Jan 22, 2013, 06:00 EST